Lawsuit Filed Soon After Scott's Filing of Merck Case

Scott + Scott, LLC (e-mail: nrothstein@scott-scott.com), has filed a class action lawsuit against Pfizer, Inc. (NYSE:PFE) in the United States District Court for the District of Connecticut on behalf of those who purchased or acquired Pfizer, Inc. securities from October 31, 2000 to December 16, 2004 (the "Class Period"). The lawsuit against Pfizer alleges the Company violated the federal securities laws by issuing materially false and misleading statements during the Class Period. New prescriptions for Pfizer's pain killer Celebrex(r), the leader in a class of drugs called cox-2 inhibitors, plummeted 56% last week just after a federal study found a link between Celebrex(r) and a heightened risk of heart attacks and strokes. This lawsuit also names individual defendants Henry A. McKinnell, who was Chairman of the Board and Chief Executive Officer and John L. LaMattina, who was President of Gobal Research and Develpoment of Pfizer. Specifically, as stated in the complaint, LaMattina was responsible for scientific reporting concerning the safety of Celebrex(r).

http://www.primezone.com/newsroom/news_releases.mhtml?d=70198